Therapeutic anticoagulation

DRUG2 trials

Sponsors

Unity Health Toronto, University of Sao Paulo General Hospital

Conditions

Anticoagulants and Bleeding DisordersCOVIDCOVID-19Coronavirus InfectionSevere Acute Respiratory SyndromeThromboembolism, Venous

Phase 3

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

CompletedNCT04362085

Unity Health TorontoCOVID-19

Start: 2020-05-11End: 2021-10-14Updated: 2025-01-30

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic

CompletedNCT04444700

University of Sao Paulo General HospitalAnticoagulants and Bleeding Disorders, Coronavirus Infection, COVID +2

Start: 2020-07-04End: 2021-10-14Updated: 2021-10-26

Related Papers

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

BMJ2021-10-14368 citations

Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.

2021-03-1020 citations